tert-butyl 2-(4-fluorobenzyl)-4-[(trifluoromethylsulfonyl)oxy]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine-7-carboxylate | 1023954-05-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机磺酸及其衍生物
• 英文名称: tert-butyl 2-(4-fluorobenzyl)-4-[(trifluoromethylsulfonyl)oxy]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine-7-carboxylate
• 英文别名: Tert-butyl 2-(4-fluorobenzyl)-4-[(trifluoromethylsulfonyl)oxy]-5,6,8,9-tetrahydro-7h-pyrimido[4,5,d]azepine-7-carboxylate；tert-butyl 2-[(4-fluorophenyl)methyl]-4-(trifluoromethylsulfonyloxy)-5,6,8,9-tetrahydropyrimido[4,5-d]azepine-7-carboxylate
• CAS: 1023954-05-3
• 化学式: C₂₁H₂₃F₄N₃O₅S
• 分子量: 505.49
• InChiKey: FMPKXDIDBMFHFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  34
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.48
• 拓扑面积：
  107
• 氢给体数：
  0
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  tert-butyl 2-(4-fluorobenzyl)-4-[(trifluoromethylsulfonyl)oxy]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine-7-carboxylate 、 4-氟苯硼酸 在 Pd(dppf)Cl*CH₂Cl₂ 1,1'-双(二苯基膦)二茂铁 、 potassium phosphate 作用下， 以 1,4-二氧六环 为溶剂， 生成 2-(4-fluoro-benzyl)-4-(4-fluoro-phenyl)-5,6,8,9-tetrahydro-pyrimido[4,5-d]azepine-7-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists

  摘要：

  The synthesis and SAR for a novel series of 2-alkyl-4-aryl-tetrahydro-pyrido-pyrimidines and 2-alkyl-4-aryl-tetrahydropyrimido-azepines is described. Representative compounds were shown to be subtype selective 5-HT2A antagonists. Optimal placement of a basic nitrogen relative to the pyrimidine and the presence of a 4-fluorophenyl group in the pyrimidine 4-position was found to have a profound effect on affinity and selectivity. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.090
• 作为产物：
  描述：

  tert-butyl 2-[(4-fluorophenyl)methyl]-4-oxo-5,6,8,9-tetrahydro-3H-pyrimido[4,5-d]azepine-7-carboxylate 、 三氟甲磺酸酐 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 2.0h， 生成 tert-butyl 2-(4-fluorobenzyl)-4-[(trifluoromethylsulfonyl)oxy]-5,6,8,9-tetrahydropyrimido[4,5-d]azepine-7-carboxylate
  参考文献：
  名称：

  2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists

  摘要：

  The synthesis and SAR for a novel series of 2-alkyl-4-aryl-tetrahydro-pyrido-pyrimidines and 2-alkyl-4-aryl-tetrahydropyrimido-azepines is described. Representative compounds were shown to be subtype selective 5-HT2A antagonists. Optimal placement of a basic nitrogen relative to the pyrimidine and the presence of a 4-fluorophenyl group in the pyrimidine 4-position was found to have a profound effect on affinity and selectivity. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2008.01.090

文献信息

• Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists
  申请人：Andrews Mark

  公开号：US20100113422A1

  公开（公告）日：2010-05-06

  The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof wherein the variables R 1 , R 2 , R 3a , R 3b , R 3b , R 3d , and R 100 are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a 5-HT 2c receptor-mediated disorders with a compound of formula (I) or a pharmaceutical composition comprising a compound of formula (I).

  本发明提供了式（I）的化合物：或其药学上可接受的盐，其中变量R1、R2、R3a、R3b、R3b、R3d和R100如本文所定义。本发明还涉及包括式（I）化合物的制药组合物，以及使用式（I）的化合物或包括式（I）的制药组合物治疗5-HT2c受体介导的疾病的方法。
• Pyrimido [4,5-D] azepine derivatives as 5-HT2c agonists
  申请人：Pfizer Inc

  公开号：US07928099B2

  公开（公告）日：2011-04-19

  The present invention provides a compound of formula (I): or a pharmaceutically acceptable salt thereof wherein the variables R1, R2, R3a, R3b, R3b, R3d, and R100 are as defined herein. The invention is also directed to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a 5-HT2c receptor-mediated disorders with a compound of formula (I) or a pharmaceutical composition comprising a compound of formula (I).

  本发明提供一种式子(I)的化合物或其药学上可接受的盐，其中变量R1、R2、R3a、R3b、R3b、R3d和R100的定义如本文所述。本发明还涉及包含式子(I)化合物的药物组合物以及使用式子(I)化合物或包含式子(I)化合物的药物组合物治疗5-HT2c受体介导的疾病的方法。
• WO2008/117169
  申请人：——

  公开号：——

  公开（公告）日：——
• US7928099B2
  申请人：——

  公开号：US7928099B2

  公开（公告）日：2011-04-19
• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists
  作者：Brock T. Shireman、Curt A. Dvorak、Dale A. Rudolph、Pascal Bonaventure、Diane Nepomuceno、Lisa Dvorak、Kirsten L. Miller、Timothy W. Lovenberg、Nicholas I. Carruthers

  DOI：10.1016/j.bmcl.2008.01.090

  日期：2008.3

  The synthesis and SAR for a novel series of 2-alkyl-4-aryl-tetrahydro-pyrido-pyrimidines and 2-alkyl-4-aryl-tetrahydropyrimido-azepines is described. Representative compounds were shown to be subtype selective 5-HT2A antagonists. Optimal placement of a basic nitrogen relative to the pyrimidine and the presence of a 4-fluorophenyl group in the pyrimidine 4-position was found to have a profound effect on affinity and selectivity. (c) 2008 Elsevier Ltd. All rights reserved.